Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses.
Debureaux PE, Cassinat B, Soret-Dulphy J, Mora B, Verger E, Maslah N, Plessier A, Rautou PE, Ollivier-Hourman I, De Ledinghen V, Goria O, Bureau C, Siracusa C, Valla D, Giraudier S, Passamonti F, Kiladjian JJ.
Debureaux PE, et al. Among authors: siracusa c.
Blood Adv. 2020 Aug 11;4(15):3708-3715. doi: 10.1182/bloodadvances.2020002414.
Blood Adv. 2020.
PMID: 32777065
Free PMC article.